ArticleNeuro-oncology2022

Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.

J Bryan Iorgulescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.